Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018
This bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.
Action Date | Type | Text | Source |
---|---|---|---|
2018-05-23 | Committee | Referred to the Subcommittee on Health. | House committee actions |
2018-05-09 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
2018-05-09 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
2018-05-09 | IntroReferral | Introduced in House | Library of Congress |